Major players in the computational biology market are Accelrys, Certara, Chemical Computing Group Inc. , Compugen Ltd. , Entelos, Inc, Genedata AG, Rhenovia Pharma SAS, Simulation Plus Inc. , Schrodinger, Leadscope, Agilent Technologies, Inc. Major players in the computational biology market are Accelrys, Certara, Chemical Computing Group Inc. , Compugen Ltd. , Entelos, Inc, Genedata AG, Rhenovia Pharma SAS, Simulation Plus Inc. , Schrodinger, Leadscope, Agilent Technologies, Inc.
→ Google ترجمة
Agilent Technologies Inc. (NYSE: A) is launching a partnership with Delaware State University (DSU), a leading historically Black university, to increase the share of underrepresented students entering STEM fields, a central mission of the company’s philanthropic work through the Agilent Foundation. Agilent will donate $1 million in addition to new lab instrumentation to help DSU expand educational
→ Google ترجمة
Major players in the microfluidics market are Illumina, Inc. , PerkinElmer, Inc. , Agilent Technologies, Inc. , Abbott Laboratories, Thermo Fisher Scientific, Qiagen, Elveflow, Cellix Ltd. , Fluidigm Corporation, Fluigent SA, Zeon Corporation, Innovative Biochips, LLC, Dolomite Microfluidics, Idex Corporation, and UFluidix. Major players in the microfluidics market are Illumina, Inc. , PerkinElmer, Inc. , Agilent Technologies, Inc. , Abbott Laboratories, Thermo Fisher Scientific, Qiagen, Elveflow, Cellix Ltd. , Fluidigm Corporation, Fluigent SA, Zeon Corporation, Innovative Biochips, LLC, Dolomite Microfluidics, Idex Corporation, and UFluidix.
→ Google ترجمة
Agilent Technologies (NYSE:A) declares $0.21/share quarterly dividend, in line with previous.Forward yield 0.66%Payable Oct. 26; for shareholders of record Oct. 4; ex-div Oct.
→ Google ترجمة
Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 21 cents per share of common stock will be paid on October 26, 2022, to all shareholders of record as of the close of business on October 4, 2022. The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors. Forward-Looking Statements This news release
→ Google ترجمة
Major players in the epigenetics market are Illumina, Thermo Fisher Scientific, Merck Millipore, Abcam, Active Motif, Bio-Rad, New England Biolabs, Agilent, Qiagen, Zymo Research, Perkinelmer, Diagenode, Hoffmann-La Roche Ltd, Eisai Co Ltd and Novartis AG. Major players in the epigenetics market are Illumina, Thermo Fisher Scientific, Merck Millipore, Abcam, Active Motif, Bio-Rad, New England Biolabs, Agilent, Qiagen, Zymo Research, Perkinelmer, Diagenode, Hoffmann-La Roche Ltd, Eisai Co Ltd and Novartis AG.
→ Google ترجمة
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #IOLT--Market leading innovator in laboratory digital transformation, Scitara, has announced a partnership with Agilent, a leader in analytical and diagnostic technologies. The announcement enables the integration of Scitara’s Scientific Integration Platform SIP with Agilent’s Software and Informatics Division portfolio of products, including chromatography software and lab workflow management solutions. Scitara’s SIP provides a universal connectivity solution in a
→ Google ترجمة
Agilent Technologies (NYSE: A ) has outperformed the market over the past 15 years by 2.32% on an annualized basis producing an average annual return of 8.73%. Currently, Agilent Technologies has a market capitalization of $38.21 billion. Buying $100 In A: If an … Full story available on Benzinga.com
→ Google ترجمة
Agilent Technologies Inc. (A)’s stock is trading at $133.85 at the moment marking a rise of 0.45% from the last session close. As of this writing, shares are priced at -24.53% less than their 52-week high of $177.36, and 18.96% over their 52-week low of $112.52. Based on the past 30-day period, the stock price […]
→ Google ترجمة
Major players in the environmental testing equipment market are Agilent Technologies Inc, Thermo Fisher Scientific Inc, Shimadzu Corporation, Waters Corporation, Bruker Corporation, PerkinElmer Inc, Merck KGaA, Teledyne Technologies Incorporated, INFICON, JEOL Ltd, SCIEX, Extech Instruments, Amphenol, and PathSensors, Inc. Major players in the environmental testing equipment market are Agilent Technologies Inc, Thermo Fisher Scientific Inc, Shimadzu Corporation, Waters Corporation, Bruker Corporation, PerkinElmer Inc, Merck KGaA, Teledyne Technologies Incorporated, INFICON, JEOL Ltd, SCIEX, Extech Instruments, Amphenol, and PathSensors, Inc.
→ Google ترجمة
Agilent Technologies Inc. (NYSE: A) today announced the company has achieved Great Place to Work Certification in 20 countries and regions, a recognition that distinguishes Agilent as a top employer based on an independent survey of its global workforce. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220914005318/en/ The 20 certified
→ Google ترجمة
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #GreatPlacetoWork--Agilent Technologies Inc. (NYSE: A) today announced the company has achieved Great Place to Work® Certification™ in 20 countries and regions, a recognition that distinguishes Agilent as a top employer based on an independent survey of its global workforce. The 20 certified countries and regions are Australia, Belgium, Brazil, Canada, China, Denmark, France, India, Ireland, Italy, Korea, Malaysia, Mexico, the Netherlands, Spain, Sweden, Taiwan, Thailand, the
→ Google ترجمة
Agilent Technologies lost about 37% of its value since its stock all-time high. Check out why I see A stock likely reaching $160 in the near term.
→ Google ترجمة
TU Wien researcher recognized for his influential work in the digitalization of bioprocesses Agilent Technologies Inc. (NYSE: A) today announced Christoph Herwig has been selected to receive a pre…
→ Google ترجمة
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced Christoph Herwig has been selected to receive a prestigious Agilent Thought Leader Award. A prominent researcher in the field of bioprocess technology, Christoph Herwig is a Professor of Biochemical Engineering at TU Wien, Vienna, Austria. Prof. Herwig’s work focuses on developing end-to-end scientific workflows in bioprocess technology. His interdisciplinary approach aims to generate a holistic process co
→ Google ترجمة
Major players in the immunofluorescence assay market are Thermo Fisher Scientific, Inc. , Abcam plc, Bio-Rad Laboratories, Inc. , PerkinElmer Inc. , Werfen Company, Merck KGaA, Agilent Technologies, Becton Dickinson and Company, Maxvision Biosciences Inc. Major players in the immunofluorescence assay market are Thermo Fisher Scientific, Inc. , Abcam plc, Bio-Rad Laboratories, Inc. , PerkinElmer Inc. , Werfen Company, Merck KGaA, Agilent Technologies, Becton Dickinson and Company, Maxvision Biosciences Inc.
→ Google ترجمة
CMI introduce new research on Global Drug Discovery covering micro level of analysis by competitors and key business segments (2022-2028). The Global Drug Discovery explores comprehensive study on various segments like opportunities, size, development, innovation, sales and overall growth of
→ Google ترجمة
The share price of Agilent Technologies Inc. (NYSE:A) rose to $128.93 per share on Thursday from $128.25. While Agilent Technologies Inc. has overperformed by 0.53%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, A fell by -26.51%, with highs and lows ranging from $179.57 to $112.52, […]
→ Google ترجمة
Wastewater data from a few major cities suggests monkeypox may have already peaked in some areas of the US. Outbreaks in New York City and San Francisco have stopped growing, though there are still many new cases. It''s too early to put monkeypox in the rearview mirror, but testing and vaccinations are ramping up. There are some early signals that monkeypox may be slowing down in areas of the US, after infecting more than 18,900 people across the US in barely three months. Wastewater data , case counts , and reported sexual activity patterns all suggest this outbreak may be turning a corner. Cristin Young, an epidemiologist who''s studying monkeypox for the private wastewater company Biobot , says it''s a little too early to say for sure that cases are declining across the entire US. Disease rates will likely continue to "vary widely" based on local availability of tests, vaccines, and education, she told Insider. Some cities are showing promising signs of turning a corner There are promising signs popping up in San Francisco , New York , San Diego , and other hard-hit areas of the country showing that both case numbers and wastewater levels of the virus are plateauing, and in some cases, declining. (Monkeypox case rates are also slowing down in other hard-hit countries around the world, including France, Germany, Spain, Portugal and the UK, leading the World Health Organization to argue that elimination of the virus is still possible across Europe .) In Los Angeles, Dr.
→ Google ترجمة
Agilent Technologies (A) and Mettler-Toledo International (MTD) are collaborating to reduce errors in sample preparation workflows for better chromatographic results.The…
→ Google ترجمة
Pune, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Downstream Processing Market by Vendor Assessment, Technology Assessment, Partner & Customer Ecosystem, type/solution, service, organization size, end-use verticals, and Region – Global Downstream Processing Market Forecast to 2030, published by Market Data Centre, The Downstream Processing Market is projected to grow at a solid pace during the forecast period. The presence of key players in the ecosystem has led to a compsetitive and diverse market. The advancement of digital transformation initiatives across multiple industries is expected to drive the worldwide Downstream Processing Market during the study period. This COVID-19 analysis of the report includes COVID-19 IMPACT on the production and, demand, supply chain. This report provides a detailed historical analysis of the global Downstream Processing Market from 2017-to 2021 and provides extensive market forecasts from 2022 to 2030 by region/country and subsectors. The report covers the revenue, sales volume, price, historical growth, and future perspectives in the Downstream Processing Market.
→ Google ترجمة
Marc N Casper , Chairman & CEO at Thermo Fisher Scientific (NYSE: TMO ), reported a large insider sell on August 29, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Casper sold 4,347 shares of Thermo Fisher Scientific . The total transaction amounted to $2,488,092. Thermo Fisher Scientific shares are trading down 0.3% at $555.0 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be … Full story available on Benzinga.com
→ Google ترجمة
CARLSBAD, Calif.--(BUSINESS WIRE)--Next-generation sequencing (NGS) is quickly becoming the platform of choice for tumor molecular profiling due to its ability to simultaneously report on multiple biomarkers. However, lengthy turnaround times can limit the clinical utility of these results. To meet the need for rapid genomic insights, Thermo Fisher Scientific today launched the CE-IVD (IVDD) Oncomine Dx Express Test and Oncomine Reporter Dx for use in clinical labs. Using targeted NGS technolog
→ Google ترجمة
The safest blue-chip dividend stocks can be pretty easy to sort out. Investing in them makes sense in turbulent times like those we are currently experiencing. Generally, blue-chip stocks that don’t pay dividends are younger firms like Amazon (NASDAQ: AMZN ) that continue to seek to accelerate growth. Blue-chip stocks represent companies with household names that have proven quality, are reliable and tend to operate profitably in good times and in bad times. In other words, they carry an inherent degree of safety overall. So, investors would be wise to start with safest blue-chip dividend stocks for the sake of safe investing. All of the stocks listed above are safe. They also have reasonably strong catalysts in their favor for the rest of 2022. TMO Thermo Fisher Scientific $576.11 KMB Kimberly-Clark $136.21 HAS Hasbro Inc. $81.68 CVX Chevron $156.90 UPS United Parcel Service $206.40 MSFT Microsoft $277.75 Thermo Fisher Scientific (TMO) Source: Michael Vi / Shutterstock.com Thermo Fisher Scientific (NYSE: TMO ) stock’s safety is inherent in its steady and predictable revenues, making it one of the safest blue-chip dividend stocks.
→ Google ترجمة
Thermo Fisher Scientific (TMO) and Structura Biotechnology are collaborating to make available a new single particle analysis software solution, Embedded CryoSPARC Live.The new…
→ Google ترجمة
Thermo Fisher Scientific Inc found using ticker (TMO) have now 22 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 715 and 525 with the average target price sitting at 662.93. With the stocks previous close at 595.01 this is indicating there is a potential upside of 11.4%. The day 50 moving average is 557.03 and the 200 moving average now moves to 579.83. The company has a market capitalisation of $230,587m. Company Website: https://www.thermofisher.com [stock_market_widget type="chart" template="basic" color="green" assets="TMO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $256,909m based on the market concensus. Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company''s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
→ Google ترجمة
Thermo Fisher has been an outstanding investment option for the investor for a couple of decades now. See why I expect 20-25% upside going forward for TMO stock.
→ Google ترجمة
Greenwich, Conn.-based Lone Pine Capital disclosed in a SEC filing that it acquired new positions in eight holdings which were largely fintech including Alphabet Class A…
→ Google ترجمة
The global "Immune Repertoire Sequencing Market" report aims to provide a detailed analysis of the factors that influence the global business adoption and segmentation outlook. The detailed information and overview of the global Immune Repertoire Sequencing market report highlight the
→ Google ترجمة
Related Stocks: OCDX , ICLR , LNTH , HCAT , TMO ,
→ Google ترجمة
Related Stocks: TMO , EL , APH , DHR , ABBV ,
→ Google ترجمة
The FDA has issued premarket approval for Thermo Fisher Scientific''s (TMO) Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients with HER2 activating mutations…
→ Google ترجمة
The global "Lab Automation Market" report aims to provide a detailed analysis of the factors that influence the global business adoption and segmentation outlook. The detailed information and overview of the global Lab Automation market report highlight the latest development
→ Google ترجمة
Related Stocks: NKE , AAPL , MSTR , TMO , ADP ,
→ Google ترجمة
Thermo Fisher Scientific (TMO) is investing $76M to expand its dry powder media manufacturing facility in Grand Island, New York to meet global demand for cell culture media, which is…
→ Google ترجمة
The stock market typically grows bumpy in the late summer as the second-quarter earnings season winds down. The fact is I believe any dip in my fundamentally superior Accelerated Profits stocks is a good buying opportunity – and based on recent action, I’m not the only one. Our friends at Bespoke recently pointed out that the bull/bear spread has dropped below 20% for only the fifth time since 1990. When the bull/bear has dropped below 20% before, the S&P 500 went on to post median returns of 2.7% in the following month, 9.19% in the next three months, 14.73% in the following six months, and 20.37% a year out. This is a very bullish signal. So, while there may be some short-term volatility, stocks are headed higher long term. In the near term, earnings are working. In other words, companies are beating estimates and that’s propelling their stock higher; and companies that miss expectations are falling. A couple of weeks ago we highlighted this with Elon Musk’s Tesla, Inc . (NASDAQ: TSLA ) after the electric car maker posted better-than-expected earnings.
→ Google ترجمة
Thermo Fisher Scientific (NYSE: TMO ) has outperformed the market over the past 20 years by 11.6% on an annualized basis producing an average annual return of 19.59%. Currently, Thermo Fisher Scientific has a market capitalization of $230.17 billion. Buying $1000 In TMO: … Full story available on Benzinga.com
→ Google ترجمة
The "Mad Money" host interviewed Thermo Fisher Scientific CEO Marc Casper on Wednesday''s episode of the show.
→ Google ترجمة
Related Stocks: CTAS , TMO , SAIA , INFO , ANSS ,
→ Google ترجمة
https://www.investing.com/news/pro/thermo-fisher-scientific-pt-raised-to-685-at-barclays-432SI-2859102
→ Google ترجمة
Pune, July 31, 2022 (GLOBE NEWSWIRE) -- Cell Line Development Market by Vendor Assessment, Technology Assessment, Partner & Customer Ecosystem, type/solution, service, organization size, end-use verticals, and Region – Global Cell Line Development Market Forecast to 2030, published by Market Data Centre, The Cell Line Development Market is projected to grow at a solid pace during the forecast period. The presence of key players in the ecosystem has led to a compsetitive and diverse market. The advancement of digital transformation initiatives across multiple industries is expected to drive the worldwide Cell Line Development Market during the study period. This COVID-19 analysis of the report includes COVID-19 IMPACT on the production and, demand, supply chain. This report provides a detailed historical analysis of the global Cell Line Development Market from 2017-to 2021 and provides extensive market forecasts from 2022-to 2030 by region/country and subsectors. The report covers the revenue, sales volume, price, historical growth, and future perspectives in the Cell Line Development Market.
→ Google ترجمة
Shares of Agilent Technologies Inc. advanced 2.66% to $131.11 Thursday, on what proved to be an all-around positive trading session for the stock market,…
→ Google ترجمة
Agilent Technologies (NYSE: A ) has outperformed the market over the past 10 years by 5.35% on an annualized basis producing an average annual return of 16.46%. Currently, Agilent Technologies has a market capitalization of $37.51 billion. Buying $1000 In A: If an … Full story available on Benzinga.com
→ Google ترجمة
The exclusive research study on ''Stem Cell Assay Market,'' which is now accessible with Coherent Market Insights, provides a complete overview of the elements driving the global business environment. This study also contains comprehensive information on the market size, commercialization
→ Google ترجمة
The global "Pharmaceutical Lab Equipment Market" report aims to provide a detailed analysis of the factors that influence the global business adoption and segmentation outlook. The detailed information and overview of the global Pharmaceutical Lab Equipment market report highlight the
→ Google ترجمة
Wall Street loves growth stocks that can increase their revenue and earnings at a faster rate than their industry or the broader market. Such shares thrive during economic expansions driven by low-interest rates, leaving investors looking for growth stocks to buy on the dip. Generally, growth stocks tend to outperform the broad market over the long term. For example, the iShares S&P 500 Growth ETF (NYSEARCA: IVW ), which tracks the S&P 500 Growth Index , has outperformed the iShares Core S&P 500 ETF (NYSEARCA: IVV ) with a 10-year average annual return of 14% versus IVV’s 13%. However, amid growing concerns over rising interest rates and a potential recession, most growth stocks have taken a severe beating in 2022. For example, IVW has fallen 21% year-to-date. By comparison, benchmark indices, the S&P 500 and Dow Jones Industrial Average , have declined by 16% and 11.8%. 7 Best Reddit Stocks to Buy Now Put another way, current challenges have pushed down the sky-high valuations of most growth shares, offering enticing buying opportunities.
→ Google ترجمة
The investment back also released an updated rating for Danaher as it expanded its coverage of the life science tools and diagnostic market.
→ Google ترجمة
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it will release financial results for the third quarter of fiscal year 2022 after the stock market closes on Tuesday, Aug. 16. The company will host a live webcast of its investor conference call in listen-only mode on the same day. Details for the webcast: Date: Tuesday, Aug. 16, 2022. Time: 1:30 p.m. Pacific time. Access: A link to join the webcast will be provided in the Upcoming Events section of Agile
→ Google ترجمة
Friday''s top analyst upgrades and downgrades included Agilent Technologies, Bunge, Duolingo, Dynatrace, Emerson Electric, Kohl’s, Lamar Advertising, Oshkosh, Regions Financial, Splunk, Spotify, XPO Logistics and more.
→ Google ترجمة
Life sciences company Agilent (A) traded lower in the early pre-market trading on Friday after Citi downgraded its shares to Neutral from Neutral, citing a change in sentiment due…
→ Google ترجمة
Cytogenetics Software Market May See A Big Move New Jersey, NJ -- ( SBWIRE ) -- 07/05/2022 -- Latest released Cytogenetics Software Market Research Report provides detailed assessment of Key and emerging players showcasing company profiles, product/service offerings, market price, and sales revenue to better derive market size estimation. With this assesment the aim is to provide viewpoint on upcoming trends, growth drivers, opinions and facts derived from industry executives with statistically supported and market validated data. Furthermore, a detailed commentary on How or Why this market may see a growth momentum during the forecast period is analysed and correlated with dominating and emerging players strength and weakness. Whats keeping Leica Biosystems, Agilent, Applied Spectral Imaging, MetaSystems, BioView, LUCIA Cytogenetics, PerkinElmer & Cytognomix gain competitive edge in Cytogenetics Software Market and stay up-to-date with available business opportunity in various segments and emerging territory.
→ Google ترجمة
Agilent Technologies''s (NYSE: A ) short percent of float has fallen 19.33% since its last report. The company recently reported that it has 2.88 million shares sold short , which is 0.96% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.5 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price … Full story available on Benzinga.com
→ Google ترجمة
Agilent is a quality company with decent growth and attractive financial profile. Read more to see why this is a good time to buy at least a starter position.
→ Google ترجمة
Agilent Technologies Inc. (NYSE:A) shares, rose in value on Friday, June 24, with the stock price up by 0.75% to the previous day’s close as strong demand from buyers drove the stock to $119.49. Actively observing the price movement in the recent trading, the stock is buoying the session at $118.60, falling within a range … Agilent Technologies Inc. (NYSE: A) Shares Are Set To Rise By 2022 Read More »
→ Google ترجمة
- ← Previous
- 1
- 2
- 3
- …
- 6
- 7
- Next →